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Abstract
The interplay between thrombosis and inflammation, termed thrombo-inflammation, causes acute organ damage in diseases 
such as ischaemic stroke and venous thrombosis. We have recently identified tetraspanin Tspan18 as a novel regulator of 
thrombo-inflammation. The tetraspanins are a family of 33 membrane proteins in humans that regulate the trafficking, clus-
tering, and membrane diffusion of specific partner proteins. Tspan18 partners with the store-operated  Ca2+ entry channel 
Orai1 on endothelial cells. Orai1 appears to be expressed in all cells and is critical in health and disease. Orai1 mutations 
cause human immunodeficiency, resulting in chronic and often lethal infections, while Orai1-knockout mice die at around the 
time of birth. Orai1 is a promising drug target in autoimmune and inflammatory diseases, and Orai1 inhibitors are in clinical 
trials. The focus of this review is our work on Tspan18 and Orai1 in Tspan18-knockout mice and Tspan18-knockdown pri-
mary human endothelial cells. Orai1 trafficking to the cell surface is partially impaired in the absence of Tspan18, resulting 
in impaired  Ca2+ signaling and impaired release of the thrombo-inflammatory mediator von Willebrand factor following 
endothelial stimulation. As a consequence, Tspan18-knockout mice are protected in ischemia–reperfusion and deep vein 
thrombosis models. We provide new evidence that Tspan18 is relatively highly expressed in endothelial cells, through the 
analysis of publicly available single-cell transcriptomic data. We also present new data, showing that Tspan18 is required 
for normal  Ca2+ signaling in platelets, but the functional consequences are subtle and restricted to mildly defective platelet 
aggregation and spreading induced by the platelet collagen receptor GPVI. Finally, we generate structural models of human 
Tspan18 and Orai1 and hypothesize that Tspan18 regulates Orai1  Ca2+ channel function at the cell surface by promoting 
its clustering.
Keywords Orai1 · Endothelial cell · Platelet · Store-operated  Ca2+ entry · Tetraspanin · Thrombo-inflammation · Tspan18
Introduction
Thrombo-inflammation is the complex interplay between 
thrombosis and inflammation that can result in acute organ 
damage [1–3]. The process is best characterized in mouse 
models of ischaemic stroke and venous thrombosis. Central 
to thrombo-inflammation is the release of ultra-large adhe-
sive strings of von Willebrand factor (VWF) from activated 
endothelial cells, in response to inflammatory mediators 
such as interleukin-1 (IL-1), IL-6, tumour necrosis factor 
α, thrombin, or histamine [2]. A proportion of the VWF 
strings remain attached to the endothelial cell surface and 
recruit platelets and leukocytes. The platelet GPIb-IX-V 
receptor complex mediates transient rolling of platelets on 
VWF, which may then firmly adhere if activated to induce 
adhesion of their αIIbβ3 integrins. Leukocytes similarly roll 
on VWF using their PSGL-1 receptor followed by stable 
adhesion via β2 integrins. Alternatively, leukocytes may be 
captured indirectly by platelets via interactions with plate-
let GPIb-IX-V or P-selectin [2]. In addition, monocytes can 
bind to VWF having first bound platelet-derived GPIb-IX-
V-positive extracellular vesicles [4]. Together, platelet and 
leukocyte recruitment lead to further recruitment of inflam-
matory cells, platelet aggregation, and blockage of vessels 
causing organ damage [1–3].
VWF is stored by endothelial cells in cigar-shaped 
vesicles called Weibel–Palade bodies (WPBs). VWF is 
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constitutively released at a relatively low level by WPB exo-
cytosis, but can be acutely exocytosed in larger quantities via 
a mechanism involving  Ca2+ signaling following endothelial 
cell activation [5]. We have recently discovered that tetraspa-
nin Tspan18 is important for endothelial cell  Ca2+ signaling, 
acute VWF release, and thrombo-inflammation, by interact-
ing with the store-operated  Ca2+ entry channel Orai1 and 
promoting its trafficking to the cell surface [6]. This review 
will describe our current knowledge of Tspan18 expression 
and function, and will speculate on the molecular mecha-
nism by which Tspan18 regulates Orai1.
The store‑operated  Ca2+ entry channel Orai1
Orai1 was identified as the long-sought-after store-operated 
 Ca2+ entry channel through three publications in 2006 [7–9]. 
 Ca2+ influx through Orai1 channels on the cell surface is 
termed store-operated  Ca2+ entry, because it is induced 
by emptying of  Ca2+ stores in the endoplasmic reticulum 
(ER). Orai1 has four transmembrane regions and intracel-
lular N- and C-termini (Fig. 1) [10]. Structural studies sug-
gest that Orai1 functions as a hexamer, forming a channel 
that mediates a characteristic  Ca2+ release-activated  Ca2+ 
current, termed  ICRAC . The  ICRAC  is distinguished by high 
 Ca2+ selectivity, a very low unitary conductance, with an 
inwardly-rectifying current-to-voltage ratio and a very posi-
tive reverse potential. The other Orai family members, Orai2 
and Orai3, are approximately 60% identical to Orai1 by pro-
tein sequence. They are less well studied, but may form their 
own  Ca2+ channels or combine with Orai1 to form hetero-
meric channels [10].
Orai1 appears to be expressed in all cells and is criti-
cal in health and disease processes. Indeed, Orai1-knockout 
mice die at around the time of birth, and Orai1 mutations in 
humans cause immunodeficiency, leading to chronic infec-
tions that are often lethal, and various non-immunological 
symptoms [11]. As previously mentioned, Orai1 channel 
opening is induced by emptying of ER  Ca2+ stores [10]. 
Such emptying is the downstream consequence of signal-
ing by cell surface receptors, including G protein-coupled 
receptors (GPCRs), receptor tyrosine kinases, and immu-
noreceptors such as B- and T-cell antigen receptors. Their 
stimulation activates phospholipase C, generating the sec-
ond messenger  IP3, which induces  Ca2+ release from  IP3 
receptor  Ca2+ channels on the ER. The release of  Ca2+ is 
sensed by ER-localized STIM1 and STIM2 proteins, which 
undergo conformational change to engage with and activate 
Orai1 channels on the cell surface in characteristic clusters, 
or puncta. The influx of  Ca2+ replenishes ER stores and, 
importantly, activates a variety of  Ca2+-responsive signal-
ing proteins to dictate cell function, such as changes in gene 
expression through activation of NFAT transcription factors 
[10].
The immunodeficiency observed in the absence of Orai1 
has made this protein a promising drug target to treat dis-
eases caused by an over-active immune system, such as 
autoimmune and inflammatory diseases [12, 13]. Indeed, 
five inhibitors of store-operated  Ca2+ entry have recently 
entered clinical trials for diseases such as acute pancreati-
tis, asthma, non-Hodgkin’s lymphoma, and the skin disease 
plaque psoriasis [12, 13]. However, based on the phenotypes 
of Orai1-deficient humans and mice, there are concerns that 
inhibition of Orai1 on every cell in the body could lead to 
toxic side effects, particularly chronic immunosuppression 
Fig. 1  Predicted structures of human Tspan18 and Orai1. Model 
structures of human Tspan18 (UniProt accession number Q96SJ8) 
and human Orai1 (UniProt accession number Q96D31) were gener-
ated with Phyre2 [62]. Human Tspan18 was modelled based on the 
crystal structure of human CD81 (PDB: 5TCX) [33]. Of the total 
protein length, 92% was predicted with 100% confidence (orange 
region) and the rest was generated ab initio (grey region). The crystal 
structures of Drosophila Orai1 subunits in open (PDB: 6BBF) [63] 
and closed (PDB: 4HKR) [64] conformations were used as templates 
for human Orai1 and yielded 100% confidence for 50% and 58% of 
the total protein length, respectively. The core Orai1 structures are 
shown; low confidence loop regions on the extracellular and intracel-
lular parts of Orai1 were omitted. Orai1 exists as a hexamer, but only 
two subunits are depicted for clarity
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and reduced muscle strength and endurance [13]. Hence, 
there is a need to more fully understand the mechanisms of 
tissue-specific Orai1 regulation, to explore whether novel, 
more selective inhibitory strategies might inhibit its function 
in disease without severe general toxicity.
Tetraspanins regulate the trafficking 
and clustering of their partner proteins
The tetraspanins are a superfamily of membrane proteins 
with four transmembrane regions that interact with specific 
partner proteins, and regulate their trafficking to the cell 
surface and subsequent lateral mobility and clustering [14, 
15]. Tetraspanins appear to exist in all multicellular organ-
isms, from plants to fungi to mammals, and there are 33 
tetraspanins in humans [16]. Examples of tetraspanin/part-
ner protein complexes are tetraspanin CD151 and laminin-
binding integrins such as α3β1 and α6β1 [17], tetraspanin 
CD81 and the B-cell receptor co-receptor CD19 [18], and 
Tspan12 and the Wnt/Norrin receptor Frizzled-4 [19]. The 
clustering of the partner appears to be the prominent role of 
CD151 and Tspan12 in these examples, whereas trafficking 
to the cell surface is the major impact of CD81 on CD19. 
In each case, tetraspanin deletion or mutation in humans 
and mice leads to phenotypes that resemble the deletion of 
the partner [17–19], thus providing genetic evidence for the 
importance of the interaction. In addition, we and others 
have shown that a subgroup of six tetraspanins, comprising 
Tspan5, 10, 14, 15, 17, and 33, and collectively known as 
the TspanC8s, interact with and regulate trafficking from the 
endoplasmic reticulum of the ‘molecular scissor’ a disinteg-
rin and metalloprotease 10 (ADAM10) [20–23]. ADAM10 
cleaves the extracellular regions from target proteins in a 
process termed ectodomain shedding. ADAM10 substrates 
number over 100 and include Notch cell fate regulators, 
amyloid precursor protein, cadherin adhesion molecules, 
growth factors, and chemokines. We have proposed a ‘six 
scissor’ hypothesis, which postulates that ADAM10 is not 
one scissor, but six different scissors with different substrates 
depending on which of the six regulatory TspanC8s it is 
associated with [20–22]. Substantial recent evidence sup-
ports this hypothesis [24–32].
Finally, tetraspanins have recently emerged as potential 
drug targets, following the discovery of the remarkable 
structure of CD81, the first tetraspanin structure to be solved 
by X-ray crystallography [33]. CD81 is cone-shaped with 
a cholesterol-binding cavity and is proposed to undergo a 
dramatic conformational change if cholesterol is removed 
[33]. This suggests that tetraspanins might function as 
‘molecular switches’ to regulate their partners, but this has 
yet to be proved. If true, it may be possible to inhibit tetras-
panin function using antibodies that lock the tetraspanin in 
a particular conformation. Alternatively, antibodies could 
inhibit by down-regulating tetraspanins or disrupting inter-
actions with partners.
Tspan18 regulates Orai1/Ca2+ signaling 
on endothelial cells
We recently reported that Orai1 is regulated by Tspan18, a 
previously uncharacterized tetraspanin in mammalian cells 
[6]. Our work was initiated by a functional screen for effects 
of tetraspanins on  Ca2+ signaling, which found that over-
expression of Tspan18, but not other tetraspanins, activates 
the  Ca2+-responsive NFAT transcription factor by 20-fold 
in an Orai1-dependent manner [6]. Furthermore, Tspan18 
co-immunoprecipitates with Orai1, but other tetraspanins 
do not. In the current absence of an effective Tspan18 anti-
body, we used RT-PCR to demonstrate Tspan18 expression 
in human endothelial cells, but not most other cell types. 
This was supported by our analyses of publicly available 
RNA-Seq data from mouse lung and brain, which showed 
that Tspan18 is most highly expressed in endothelial cells of 
these organs [6]. Analysis of single-cell RNA-Seq data from 
20 mouse organs provides further support, since 9 of the 
14 most highly Tspan18-expressing cell types are endothe-
lial cells (Fig. 2) [34]. Tspan18 is not entirely restricted to 
endothelial cells, since there is notable expression in blad-
der cells and weaker expression in certain other cell types 
(Fig. 2).
We further showed that Tspan18 knockdown in pri-
mary human umbilical vein endothelial cells (HUVECs) 
impairs  Ca2+ signaling by 55–70% following stimulation 
with the GPCR agonists histamine or thrombin, similar to 
Orai1 knockdown [6]. Orai1 surface localisation is 70% 
reduced following Tspan18 knockdown, suggesting a role 
for Tspan18 in trafficking Orai1 from the ER. Tspan18-
knockout mice are grossly normal and breed as both 
homozygote knockouts and heterozygotes, the latter yield-
ing offspring at Mendelian ratios. However, the Tspan18-
knockout mice display endothelial defects that yield partial 
protection in two thrombo-inflammatory models: a deep 
vein thrombosis model (60% reduction in thrombus size) 
and an ischemia–reperfusion injury heart attack model (50% 
reduced platelet deposition). Furthermore, there is a 90% 
and 50% reduction in agonist-induced release of VWF from 
endothelial cells in vitro and in vivo models, respectively 
[6]. Together, our data strongly suggest that Tspan18 inter-
acts with Orai1 and regulates its trafficking to the endothelial 
cell surface, a process which is critical for normal endothe-
lial cell  Ca2+ signaling and consequent thrombo-inflamma-
tory responses.
In addition to their thrombo-inflammatory phenotypes, 
Tspan18-knockout mice have a haemostasis defect, as 
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detected by increased blood loss in a tail bleeding assay 
[6]. Consistent with a role for Tspan18 in endothelial cells, 
this bleeding phenotype is the result of Tspan18 deletion 
from non-haematopoietic cells only; this was determined 
using wild-type/Tspan18-knockout fetal liver chimeric 
mice [6]. The underlying mechanism remains unclear, 
since there is no evidence that an acute release of VWF 
from endothelial cells following injury is critical for hae-
mostasis. However, we hypothesize that in the context 
of the tail bleeding assay, activation of endothelial cells 
proximal to the tail cut would lead to  Ca2+ entry via Orai1 
channels, followed by VWF release and platelet recruit-
ment, such that cessation of bleeding would be quicker 
than in the absence of such VWF release. The haemosta-
sis defect in endothelial-specific VWF-knockout mice [35, 
36] would appear to support this hypothesis. However, 
interpretation of these data is complicated by the strik-
ingly reduced VWF concentration in the plasma of these 
mice, which is thought to be responsible for increased 
bleeding [35, 36]. Plasma VWF concentration is normal 
in Tspan18-knockout mice [6], and thus, we believe that 
Tspan18/Orai1/Ca2+ signaling is important for acute VWF 
Fig. 2  Tspan18 is preferentially 
expressed by endothelial cells. 
Mouse Tspan18 expression was 
analysed from publicly available 
single-cell RNA-Seq data sets 
from the Tabula Muris Con-
sortium [34], which contains 
data from 53,760 cells from 
20 organs or tissues of seven 
mice. Tabula Muris data for 
gene counts from cells sorted by 
flow cytometry were normal-
ized to counts per million (cpm) 
and presented as ln(1 + cpm). 
Data from the top 20 cell types 
(tissue of origin in brackets), 
ranked by mean expression, 
were visualized as violin plots; 
n represents number of cells
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release following cell activation, in contrast to the rela-
tively low-level release of VWF that is known to occur 
constitutively [5]. We propose that acute VWF release has 
a role in promoting haemostasis, but this will be challeng-
ing to test experimentally.
A recent study identifies the Tspan18 orthologue 
tspan18b as an endothelial-expressed gene in zebrafish, 
which is required for normal blood vessel development, 
but its mechanism of action was not investigated [37]. 
Since VWF is known to promote blood vessel development 
[38], we propose that impaired Orai1/Ca2+ signaling and 
impaired VWF release may be responsible for the pheno-
type in tspan18b-knockdown zebrafish. Thus, the role of 
Tspan18 in regulating Orai1/Ca2+ signaling in endothelial 
cells may be conserved across diverse vertebrate species. 
It remains to be determined whether blood vessel devel-
opment may also be impaired in Tspan18-knockout mice, 
although the grossly normal vasculature in adult kidney, 
pancreas, and ear [6] suggests that any developmental 
defect may only be subtle or delayed.
An emerging idea in the Orai1 field is that the extent 
of clustering (promoted by STIM proteins) affects the 
nature of the ensuing  Ca2+ signal and downstream cel-
lular responses [39, 40]. We hypothesize that Tspan18 
provides an additional mechanism of Orai1 clustering in 
endothelial cells, and that Tspan18/Orai1 complexes may 
create a  Ca2+ channel with membrane dynamics and elec-
trophysiological properties that are distinct from Orai1 
alone. A predicted structural model of Tspan18, based 
on the crystal structure of CD81 [33], is shown along-
side the crystal structures of the Orai1 channel in closed 
and open conformations, to show the comparative dimen-
sions of the proteins (Fig. 1); it has yet to be determined 
if Tspan18 interacts with higher affinity to the closed or 
open forms. Mechanistically, Tspan18 may pre-cluster 
Orai1 channels, resulting in stronger, more rapid  Ca2+ 
signaling in response to agonists, which may be critical 
for endothelial cell function in blood vessel growth and 
in thrombo-inflammation. Furthermore, the proposed 
function of tetraspanins as molecular switches [33] might 
enable Tspan18 to modulate Orai1 via conformational 
change. We believe that Tspan18 is a potential drug tar-
get for the treatment of endothelial-driven inflammatory 
diseases, cancer angiogenesis, and retinal neovascularisa-
tion, which is the most common form of vision loss in 
the western world. Importantly, targeting Tspan18 may 
enable Orai1 inhibition in a relatively endothelial-specific 
manner, so avoiding the likely toxicity that would result 
from inhibiting this important  Ca2+ channel on all cells in 
the body. Targeting tetraspanins is not without precedent, 
since an antibody to tetraspanin CD37 is in clinical trials 
for chronic lymphocytic leukaemia [41].
A subtle role for Tspan18 in platelet  Ca2+ 
signaling and aggregation
In addition to the cell types included in Fig. 2, Tspan18 has 
been detected in human platelets by proteomics [42, 43], 
and in human and mouse platelets and megakaryocytes at 
the mRNA level [44–46]. Platelets have a pivotal role in 
haemostasis, but the bleeding phenotype in the Tspan18-
knockout mice is not due to platelet dysfunction, because 
the experiments with fetal liver chimeras showed that this 
is a result of Tspan18 deletion in non-haematopoietic cells 
[6]. Furthermore, Tspan18-knockout platelets aggregate 
normally in response to the platelet agonists collagen or 
thrombin [6].
To investigate whether Tspan18 has some role in 
platelet  Ca2+ signaling, platelets were loaded with the 
 Ca2+-sensitive dye Fura-2-AM. Platelets were stimulated 
with collagen-related peptide, a specific agonist for the 
collagen receptor GPVI which activates platelets via non-
receptor tyrosine kinase signaling. Intracellular  Ca2+ con-
centrations were then monitored with a fluorimeter. The 
rate of cellular  Ca2+ accumulation and the maximal  Ca2+ 
concentration after 10 min were significantly reduced in 
Tspan18-knockout platelets (Fig. 3a). A similar result was 
obtained following stimulation with collagen (Fig. 3b). No 
significant effect was observed following stimulation with 
thrombin, which activates platelets via a GPCR (Fig. 3c). 
To assess store-operated  Ca2+ entry, platelets were treated 
in the absence of extracellular  Ca2+ with thapsigargin, 
which inhibits sarco/endoplasmic reticulum  Ca2+-ATPase 
channels to cause  Ca2+ store emptying. A reduction in the 
rate of release and maximal  Ca2+ increase was observed 
in Tspan18-knockout platelets (Fig. 3d). Subsequent addi-
tion of extracellular  Ca2+ to the platelets, allowing store-
operated  Ca2+ entry to occur, revealed impaired  Ca2+ entry 
in the absence of Tspan18 (Fig. 3e).
To further explore a potential functional role for 
Tspan18 in platelets, in vitro aggregation assays were 
employed. Defective aggregation of Tspan18-knockout 
platelets was observed in response to the collagen-related 
peptide at the intermediate concentration (Fig. 4a), which 
was partially rescued at high concentration (Fig.  4b). 
However, aggregation induced by the physiological ago-
nist for GPVI, collagen, which also binds α2β1 integrin, 
was normal for Tspan18-knockout platelets (Fig. 4c, d), as 
we previously reported [6]. Aggregation was also normal 
when induced by threshold levels of other platelet ago-
nists, such as anti-CLEC-2 antibody, thrombin, or ADP 
(Fig. 4e–h). To determine whether this GPVI-specific 
aggregation defect extends to platelet spreading, plate-
lets were plated on glass coverslips coated with collagen-
related peptide or fibrinogen; the latter binds to αIIbβ3, the 
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major platelet integrin. Tspan18-knockout platelet spread-
ing was impaired on collagen-related peptide but normal 
on fibrinogen (Fig. 5a). When aggregate formation on col-
lagen was assessed in whole blood using a flow-adhesion 
system, no defect in dynamics or total coverage area of 
platelet aggregates was observed for Tspan18-knockout 
platelets (Fig. 5b). Together, these data suggest a relatively 
mild but specific defect in GPVI-induced activation in the 
absence of Tspan18, which can be overcome at high doses 
of collagen-related peptide or by collagen, the latter which 
engages both GPVI and α2β1 integrin; it is possible that 
signaling induced by the collagen-binding integrin α2β1 
[47, 48] is sufficient to overcome the mild GPVI-specific 
aggregation defect.
GPVI signals via an immunoreceptor tyrosine-based acti-
vation motif (ITAM) within its associated FcRγ chain, to 
activate non-receptor tyrosine kinases of the Src, Syk, and 
Btk families and downstream phospholipase C (PLC) γ2 and 
 Ca2+ signaling. The idea that GPVI signaling is impaired 
in Tspan18-knockout platelets because of impaired Orai1 
function is supported by normal upstream signaling, namely 
tyrosine phosphorylation in response to collagen-related 
peptide (Fig. 6). Interestingly, in Orai1-knockout plate-
lets, store-operated  Ca2+ entry is reduced by 80–90%, but 
the aggregation defect is specific to GPVI [49]. It remains 
unclear why GPVI-induced platelet aggregation is so reliant 
on Orai1, but the similarities in phenotype between Orai1 
and Tspan18 deficiencies are consistent with the idea that 
Orai1 is Tspan18-regulated. Additional roles for Tspan18: chick 
embryonic development and links 
to schizophrenia
Before our recent characterization of Tspan18, the only 
functional studies on Tspan18 were in chick embryos, in 
which Tspan18 is required for neural crest cell migration, 
albeit without a major effect on embryonic development [50, 
51]. Neural crest cells are a population of cells that arise 
Fig. 3  GPVI-induced  Ca2+ signaling and store-operated  Ca2+ entry 
is reduced in Tspan18-knockout platelets. Washed platelets from 
 Tspan18+/+ and  Tspan18−/− mice were loaded with the  Ca2+ sensi-
tive dye Fura-2 AM and  Ca2+ measurements taken using a lumines-
cence spectrophotometer. Collated data were fitted to an exponential 
one-phase association equation, shown in the left-hand panels, and 
maximal  Ca2+ concentration was calculated, shown in the right-hand 
column. Platelets were stimulated with a 1  μg/ml collagen-related 
peptide (CRP), b 3 μg/ml collagen, and c 0.06 units/ml thrombin. d 
Platelets were treated in the absence of extracellular  Ca2+ with thapsi-
gargin (TG) to induce emptying of the intracellular  Ca2+ stores. e The 
experiment in panel (d) was extended by the addition of 1.5 mM  Ca2+ 
to the extracellular buffer. The rate constants were compared using 
an f test (*** denotes P < 0.001). Maximal  Ca2+ concentrations were 
analysed by t test (* denotes P < 0.05; ns denotes not significant). 
Error bars represent the standard error of the mean from 2–6 inde-
pendent experiments. Detailed methods are available online (https ://
ethes es.bham.ac.uk/id/eprin t/5903/)
▸
559Medical Microbiology and Immunology (2020) 209:553–564 
1 3
transiently during vertebrate development from the ectoderm 
germ layer. They undergo epithelial-to-mesenchymal transi-
tion to migrate and differentiate into a diverse range of cell 
types. Tspan18 mRNA is expressed in pre-migratory neural 
crest cells, but is down-regulated when the cells migrate, 
and forced Tspan18 over-expression prevents migration 
[51]. There is no evidence that Tspan18 is regulating Orai1/
Ca2+ signaling in this process. Instead, Tspan18 expression 
stabilizes the expression of the cell–cell adhesion molecule 
cadherin 6 at the protein level; down-regulation of cadherin 
6-mediated cell–cell interactions is important to allow 
the cells to disengage from each other and migrate [51]. 
It has yet to be investigated if Tspan18 regulates cadherin 
6 in mammalian cells. Cadherin 6 does not appear to be 
expressed in endothelial cells in mice [34]. Indeed, cadherin 
6 is not expressed by most normal cell types, and is best 
Fig. 4  Tspan18-deficient platelets have a specific aggregation defect 
downstream of GPVI. Mouse platelets were isolated from whole 
blood taken from  Tspan18+/+ and  Tspan18−/− mice. Washed plate-
lets were activated with a 3 µg/ml or b 10 µg/ml of the GPVI-specific 
agonist collagen-related peptide (CRP), c 1 µg/ml or d 3 µg/ml col-
lagen, e 1 µg/ml or f 10 µg/ml CLEC-2 antibody, or g 0.03 units/ml 
thrombin. h Platelets in PRP were activated with 1 µM ADP. Aggre-
gation was measured via light transmission with stirring. Representa-
tive traces are shown in the upper panels and quantitated % aggre-
gation per minute shown in the lower panels. A two-way ANOVA 
was performed on arcsine-transformed data (* denotes P < 0.05, ** 
denotes P < 0.01 and *** denotes P < 0.001). Error bars represent the 
standard error of the mean from 3–9 pairs of mice. Detailed methods 
are available online  (https ://ethes es.bham.ac.uk/id/eprin t/5903/)
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studied for its expression on renal, ovarian, and thyroid can-
cers [52]. One cell type in which Tspan18 and cadherin 6 are 
co-expressed is the platelet. Cadherin 6 blocking strategies 
suggested a subtle role for cadherin 6 in platelet aggregation 
via interaction with the major platelet integrin αIIbβ3 [53], 
but a physical and functional interaction between cadherin 
6 and Tspan18 on platelets has yet to be explored.
A genome-wide association study on schizophrenia 
in the Han Chinese population implicated three single-
nucleotide polymorphisms in the 5′ untranslated region 
of Tspan18 [54]. However, this remains controversial, 
because these polymorphisms were not replicated in all 
follow-up studies [55–58]. Nevertheless, altered Tspan18 
expression in brain endothelial cell or other brain cell 
types could affect Orai1/Ca2+ signaling and impact brain 
function and neurological disorders such as schizophre-
nia. For instance, Tspan18 on endothelial cells could be 
important for brain function, since endothelial dysfunction 
in the brain and inflammation is linked to neurological 
disorders [59, 60]. Alternatively, Tspan18 on microglial 
cells (Fig. 2) could impact on their capacity to mediate 
synaptic pruning, an excess of which was recently linked 
to schizophrenia [61].
Fig. 5  Tspan18-deficient platelets have a specific spreading defect 
downstream of GPVI, but aggregate formation under flow is nor-
mal. a Washed platelets from  Tspan18+/+ and  Tspan18−/− mice were 
exposed to coverslips coated with 10 µg/ml collagen-related peptide 
(CRP) or 100 µg/ml fibrinogen. The area of the adhered platelets was 
measured and quantitated. Upper panels show quantitation in the 
form of violin plots from 4 pairs of mice (150 platelets were analysed 
per mouse). All data were analysed by t test (*** denotes P < 0.001, 
ns denotes not significant). Lower panels are representative DIC 
microscopy images. b Whole blood from  Tspan18+/+ and  Tspan18−/− 
mice was perfused over a collagen-coated flow cell (30 µg/ml) using 
the Fluxion Bioflux system at a shear rate of 1000 s−1. Coverage of 
the flow cell by aggregates was measured at 1  min intervals, using 
thresholding in ImageJ. The upper panel shows quantitated data; a 
two-way ANOVA with Bonferroni post-test was performed on arc-
sine-transformed data. Error bars represent the standard error of the 
mean from three pairs of mice. Lower panels show representative 
fluorescence images taken at 1  min intervals. Detailed methods are 
available online (https ://ethes es.bham.ac.uk/id/eprin t/5903/)
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Résumé and outlook
In summary, Tspan18 is important in endothelial cells for 
the cell surface localization of Orai1,  Ca2+ signaling, and 
VWF release. As a result, Tspan18 deficiency is protective 
in thrombo-inflammatory models of venous thrombosis 
and ischemia–reperfusion injury in the heart.  Ca2+ sign-
aling and VWF are both critical to endothelial function 
in haemostasis, inflammation, blood vessel growth, and 
angiogenesis [5, 38]. Future work should investigate the 
importance of Tspan18 in these processes using mouse 
models of atherosclerosis, ischaemic stroke, and angiogen-
esis. Generation of Tspan18 monoclonal antibodies will 
also be important to determine the expression profile of 
Tspan18 at the protein level. Moreover, such antibodies 
may have inhibitory activity and, thus, therapeutic poten-
tial for thrombo-inflammatory diseases such as deep vein 
thrombosis, retinal neovascularisation, and cancer angio-
genesis to deprive a growing tumour of its blood supply. 
Finally, it will be interesting to investigate the mecha-
nism by which Tspan18 facilitates Orai1 trafficking to the 
endothelial cell surface. Once at the cell surface, it will be 
important to determine whether and how Tspan18 regu-
lates Orai1 clustering and/or channel opening. We may 
then understand why a process as fundamental as store-
operated  Ca2+ entry is modified by Tspan18 in cells such 
as endothelial cells, but not in others.
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pairs of mice. Detailed methods are available online (https ://ethes 
es.bham.ac.uk/id/eprin t/5903/)
562 Medical Microbiology and Immunology (2020) 209:553–564
1 3
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Chen J, Chung DW (2018) Inflammation, von Willebrand 
factor, and ADAMTS13. Blood 132(2):141–147. https ://doi.
org/10.1182/blood -2018-02-76900 0
 2. Denorme F, Vanhoorelbeke K, De Meyer SF (2019) von Wille-
brand factor and platelet glycoprotein Ib: a thromboinflam-
matory axis in stroke. Front Immunol 10:2884. https ://doi.
org/10.3389/fimmu .2019.02884 
 3. Stegner D, Klaus V, Nieswandt B (2019) Platelets as modu-
lators of cerebral ischemia/reperfusion injury. Front Immunol 
10:2505. https ://doi.org/10.3389/fimmu .2019.02505 
 4. Chimen M, Evryviadou A, Box CL, Harrison MJ, Hazeldine 
J, Dib LH, Kuravi SJ, Payne H, Price JMJ, Kavanagh D, Iqbal 
AJ, Lax S, Kalia N, Brill A, Thomas SG, Belli A, Crombie 
N, Adams RA, Evans SA, Deckmyn H, Lord JM, Harrison P, 
Watson SP, Nash GB, Rainger GE (2019) Appropriation of 
GPIbalpha from platelet-derived extracellular vesicles supports 
monocyte recruitment in systemic inflammation. Haematolog-
ica. https ://doi.org/10.3324/haema tol.2018.21514 5
 5. McCormack JJ, Lopes da Silva M, Ferraro F, Patella F, Cut-
ler DF (2017) Weibel-Palade bodies at a glance. J Cell Sci 
130(21):3611–3617. https ://doi.org/10.1242/jcs.20803 3
 6. Noy PJ, Gavin RL, Colombo D, Haining EJ, Reyat JS, Payne H, 
Thielmann I, Lokman AB, Neag G, Yang J, Lloyd T, Harrison 
N, Heath VL, Gardiner C, Whitworth KM, Robinson J, Koo 
CZ, Di Maio A, Harrison P, Lee SP, Michelangeli F, Kalia N, 
Rainger GE, Nieswandt B, Brill A, Watson SP, Tomlinson MG 
(2019) Tspan18 is a novel regulator of the Ca(2+) channel Orai1 
and von Willebrand factor release in endothelial cells. Hae-
matologica 104(9):1892–1905. https ://doi.org/10.3324/haema 
tol.2018.19424 1
 7. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa 
B, Hogan PG, Lewis RS, Daly M, Rao A (2006) A mutation in 
Orai1 causes immune deficiency by abrogating CRAC channel 
function. Nature 441(7090):179–185. https ://doi.org/10.1038/
natur e0470 2
 8. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-
Huberson M, Kraft S, Turner H, Fleig A, Penner R, Kinet JP 
(2006) CRACM1 is a plasma membrane protein essential for 
store-operated Ca2+ entry. Science 312(5777):1220–1223. https 
://doi.org/10.1126/scien ce.11278 83
 9. Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, 
Roos J, Stauderman KA, Cahalan MD (2006) Genome-wide 
RNAi screen of Ca(2+) influx identifies genes that regulate 
Ca(2+) release-activated Ca(2+) channel activity. Proc Natl 
Acad Sci USA 103(24):9357–9362. https ://doi.org/10.1073/
pnas.06031 61103 
 10. Qiu R, Lewis RS (2019) Structural features of STIM and Orai 
underlying store-operated calcium entry. Curr Opin Cell Biol 
57:90–98. https ://doi.org/10.1016/j.ceb.2018.12.012
 11. Feske S (2019) CRAC channels and disease—from human 
CRAC channelopathies and animal models to novel drugs. 
Cell Calcium 80:112–116. https ://doi.org/10.1016/j.
ceca.2019.03.004
 12. Mammadova-Bach E, Nagy M, Heemskerk JWM, Nieswandt 
B, Braun A (2019) Store-operated calcium entry in thrombosis 
and thrombo-inflammation. Cell Calcium 77:39–48. https ://doi.
org/10.1016/j.ceca.2018.11.005
 13. Stauderman KA (2018) CRAC channels as targets for drug dis-
covery and development. Cell Calcium 74:147–159. https ://doi.
org/10.1016/j.ceca.2018.07.005
 14. Termini CM, Gillette JM (2017) Tetraspanins function as regu-
lators of cellular signaling. Front Cell Dev Biol 5:34. https ://
doi.org/10.3389/fcell .2017.00034 
 15. van Deventer SJ, Dunlock VE, van Spriel AB (2017) Molecu-
lar interactions shaping the tetraspanin web. Biochem Soc Trans 
45(3):741–750. https ://doi.org/10.1042/BST20 16028 4
 16. Charrin S, Jouannet S, Boucheix C, Rubinstein E (2014) Tetras-
panins at a glance. J Cell Sci 127(Pt 17):3641–3648. https ://doi.
org/10.1242/jcs.15490 6
 17. Hemler ME (2014) Tetraspanin proteins promote multiple cancer 
stages. Nat Rev Cancer 14(1):49–60
 18. Levy S (2014) Function of the tetraspanin molecule CD81 
in B and T cells. Immunol Res 58(2–3):179–185. https ://doi.
org/10.1007/s1202 6-014-8490-7
 19. Tomlinson MG (2017) Eye-opening potential for tetraspanin 
Tspan12 as a therapeutic target for diseases of the retinal vascula-
ture. Circulation 136(2):196–199. https ://doi.org/10.1161/CIRCU 
LATIO NAHA.117.02852 1
 20. Matthews AL, Koo CZ, Szyroka J, Harrison N, Kanhere A, Tom-
linson MG (2018) Regulation of leukocytes by TspanC8 tetras-
panins and the "Molecular Scissor" ADAM10. Front Immunol 
9:1451. https ://doi.org/10.3389/fimmu .2018.01451 
 21. Matthews AL, Noy PJ, Reyat JS, Tomlinson MG (2017) Regu-
lation of a disintegrin and metalloproteinase (ADAM) family 
sheddases ADAM10 and ADAM17: the emerging role of tet-
raspanins and rhomboids. Platelets 28(4):333–341. https ://doi.
org/10.1080/09537 104.2016.11847 51
 22. Matthews AL, Szyroka J, Collier R, Noy PJ, Tomlinson MG 
(2017) Scissor sisters: regulation of ADAM10 by the TspanC8 
tetraspanins. Biochem Soc Trans 45(3):719–730. https ://doi.
org/10.1042/BST20 16029 0
 23. Saint-Pol J, Eschenbrenner E, Dornier E, Boucheix C, Charrin S, 
Rubinstein E (2017) Regulation of the trafficking and the function 
of the metalloprotease ADAM10 by tetraspanins. Biochem Soc 
Trans 45(4):937–944. https ://doi.org/10.1042/BST20 16029 6
 24. Brummer T, Muller SA, Pan-Montojo F, Yoshida F, Fellgiebel A, 
Tomita T, Endres K, Lichtenthaler SF (2019) NrCAM is a marker 
for substrate-selective activation of ADAM10 in Alzheimer’s 
disease. EMBO Mol Med 11(4):e9695. https ://doi.org/10.15252 /
emmm.20180 9695
 25. Dornier E, Coumailleau F, Ottavi JF, Moretti J, Boucheix C, Mau-
duit P, Schweisguth F, Rubinstein E (2012) TspanC8 tetraspanins 
regulate ADAM10/Kuzbanian trafficking and promote Notch acti-
vation in flies and mammals. J Cell Biol 199(3):481–496. https ://
doi.org/10.1083/jcb.20120 1133
 26. Eschenbrenner E, Jouannet S, Clay D, Chaker J, Boucheix C, Brou 
C, Tomlinson MG, Charrin S, Rubinstein E (2020) TspanC8 tet-
raspanins differentially regulate ADAM10 endocytosis and half-
life. Life Sci Alliance. https ://doi.org/10.26508 /lsa.20190 0444
 27. Jouannet S, Saint-Pol J, Fernandez L, Nguyen V, Charrin S, 
Boucheix C, Brou C, Milhiet PE, Rubinstein E (2016) TspanC8 
tetraspanins differentially regulate the cleavage of ADAM10 
substrates, Notch activation and ADAM10 membrane com-
partmentalization. Cell Mol Life Sci 73:1895–1915. https ://doi.
org/10.1007/s0001 8-015-2111-z
563Medical Microbiology and Immunology (2020) 209:553–564 
1 3
 28. Koo CZ, Harrison N, Noy PJ, Szyroka J, Matthews AL, Hsia HE, 
Muller SA, Tushaus J, Goulding J, Willis K, Apicella C, Cragoe 
B, Davis E, Keles M, Malinova A, McFarlane TA, Morrison PR, 
Nguyen HTH, Sykes MC, Ahmed H, Di Maio A, Seipold L, Saftig 
P, Cull E, Pliotas C, Rubinstein E, Poulter NS, Briddon SJ, Holli-
day ND, Lichtenthaler SF, Tomlinson MG (2020) The tetraspanin 
Tspan15 is an essential subunit of an ADAM10 scissor complex. 
J Biol Chem. https ://doi.org/10.1074/jbc.RA120 .01260 1
 29. Noy PJ, Yang J, Reyat JS, Matthews AL, Charlton AE, Furmston 
J, Rogers DA, Rainger GE, Tomlinson MG (2016) TspanC8 tet-
raspanins and a disintegrin and metalloprotease 10 (ADAM10) 
interact via their extracellular regions: evidence for distinct bind-
ing mechanisms for different TspanC8 proteins. J Biol Chem 
291(7):3145–3157. https ://doi.org/10.1074/jbc.M115.70305 8
 30. Reyat JS, Chimen M, Noy PJ, Szyroka J, Rainger GE, Tomlin-
son MG (2017) ADAM10-interacting tetraspanins Tspan5 and 
Tspan17 regulate VE-cadherin expression and promote T lym-
phocyte transmigration. J Immunol 199(2):666–676. https ://doi.
org/10.4049/jimmu nol.16007 13
 31. Saint-Pol J, Billard M, Dornier E, Eschenbrenner E, Danglot L, 
Boucheix C, Charrin S, Rubinstein E (2017) New insights into 
the tetraspanin Tspan5 using novel monoclonal antibodies. J 
Biol Chem 292(23):9551–9566. https ://doi.org/10.1074/jbc.
M116.76566 9
 32. Seipold L, Altmeppen H, Koudelka T, Tholey A, Kasparek P, 
Sedlacek R, Schweizer M, Bar J, Mikhaylova M, Glatzel M, Saftig 
P (2018) In vivo regulation of the A disintegrin and metallopro-
teinase 10 (ADAM10) by the tetraspanin 15. Cell Mol Life Sci 
75:3251–3267. https ://doi.org/10.1007/s0001 8-018-2791-2
 33. Zimmerman B, Kelly B, McMillan BJ, Seegar TC, Dror RO, 
Kruse AC, Blacklow SC (2016) Crystal structure of a full-length 
human tetraspanin reveals a cholesterol-binding pocket. Cell 
167(4):1041–1051. https ://doi.org/10.1016/j.cell.2016.09.056
 34. Tabula Muris C (2018) Overall c, Logistical c, Organ c, process-
ing, Library p, sequencing, Computational data a, Cell type a, 
Writing g, Supplemental text writing g, Principal i. Single-cell 
transcriptomics of 20 mouse organs creates a Tabula Muris. 
Nature 562(7727):367–372. https ://doi.org/10.1038/s4158 
6-018-0590-4
 35. Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR 
(2012) Contribution of platelet vs. endothelial VWF to platelet 
adhesion and hemostasis. J Thromb Haemost 10(8):1646–1652. 
https ://doi.org/10.1111/j.1538-7836.2012.04797 .x
 36. Verhenne S, Denorme F, Libbrecht S, Vandenbulcke A, Pareyn 
I, Deckmyn H, Lambrecht A, Nieswandt B, Kleinschnitz C, 
Vanhoorelbeke K, De Meyer SF (2015) Platelet-derived VWF 
is not essential for normal thrombosis and hemostasis but fosters 
ischemic stroke injury in mice. Blood 126(14):1715–1722. https 
://doi.org/10.1182/blood -2015-03-63290 1
 37. Marass M, Beisaw A, Gerri C, Luzzani F, Fukuda N, Gunther 
S, Kuenne C, Reischauer S, Stainier DYR (2019) Genome-wide 
strategies reveal target genes of Npas4l associated with vascular 
development in zebrafish. Development. https ://doi.org/10.1242/
dev.17342 7
 38. Randi AM, Smith KE, Castaman G (2018) von Willebrand factor 
regulation of blood vessel formation. Blood 132(2):132–140. https 
://doi.org/10.1182/blood -2018-01-76901 8
 39. Yen M, Lewis RS (2019) Numbers count: how STIM and Orai 
stoichiometry affect store-operated calcium entry. Cell Calcium 
79:35–43. https ://doi.org/10.1016/j.ceca.2019.02.002
 40. Zhou Y, Cai X, Nwokonko RM, Loktionova NA, Wang Y, Gill 
DL (2017) The STIM-Orai coupling interface and gating of the 
Orai1 channel. Cell Calcium 63:8–13. https ://doi.org/10.1016/j.
ceca.2017.01.001
 41. Stilgenbauer S, Aurran Schleinitz T, Eichhorst B, Lang F, Offner 
F, Rossi JF, Schroyens W, Van Den Neste E, Ysebaert L, von 
Wangenheim U, Ursula Kress U, Blum P, Zenz T (2019) Phase 
1 first-in-human trial of the anti-CD37 antibody BI 836826 in 
relapsed/refractory chronic lymphocytic leukemia. Leukemia. 
https ://doi.org/10.1038/s4137 5-019-0475-z
 42. Lewandrowski U, Wortelkamp S, Lohrig K, Zahedi RP, Wolters 
DA, Walter U, Sickmann A (2009) Platelet membrane proteomics: 
a novel repository for functional research. Blood 114(1):e10–19
 43. Tomlinson MG (2009) Platelet tetraspanins: small but interest-
ing. J Thromb Haemost 7(12):2070–2073. https ://doi.org/10.111
1/j.1538-7836.2009.03613 .x
 44. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, 
Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwag-
inga JJ, Watkins NA, van der Schoot CE, Ouwehand WH (2007) 
Comparative gene expression profiling of in vitro differentiated 
megakaryocytes and erythroblasts identifies novel activatory and 
inhibitory platelet membrane proteins. Blood 109(8):3260–3269
 45. Protty MB, Watkins NA, Colombo D, Thomas SG, Heath VL, 
Herbert JM, Bicknell R, Senis YA, Ashman LK, Berditchevski F, 
Ouwehand WH, Watson SP, Tomlinson MG (2009) Identification 
of Tspan9 as a novel platelet tetraspanin and the collagen receptor 
GPVI as a component of tetraspanin microdomains. Biochem J 
417(1):391–400
 46. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, 
Yost CC, Zimmerman GA, Weyrich AS (2011) Genome-wide 
RNA-seq analysis of human and mouse platelet transcriptomes. 
Blood 118(14):e101–111. https ://doi.org/10.1182/blood -2011-03-
33970 5
 47. Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP 
(2003) Integrin alpha2beta1 mediates outside-in regulation of 
platelet spreading on collagen through activation of Src kinases 
and PLCgamma2. J Cell Biol 160(5):769–780
 48. Mazzucato M, Cozzi MR, Battiston M, Jandrot-Perrus M, Mongiat 
M, Marchese P, Kunicki TJ, Ruggeri ZM, De Marco L (2009) Dis-
tinct spatio-temporal Ca2+ signaling elicited by integrin alpha-
2beta1 and glycoprotein VI under flow. Blood 114(13):2793–
2801. https ://doi.org/10.1182/blood -2008-12-19349 0
 49. Braun A, Varga-Szabo D, Kleinschnitz C, Pleines I, Bender 
M, Austinat M, Bosl M, Stoll G, Nieswandt B (2009) Orai1 
(CRACM1) is the platelet SOC channel and essential for patho-
logical thrombus formation. Blood 113(9):2056–2063. https ://doi.
org/10.1182/blood -2008-07-17161 1
 50. Fairchild CL, Conway JP, Schiffmacher AT, Taneyhill LA, Gam-
mill LS (2014) FoxD3 regulates cranial neural crest EMT via 
downregulation of tetraspanin18 independent of its functions 
during neural crest formation. Mech Dev 132:1–12. https ://doi.
org/10.1016/j.mod.2014.02.004
 51. Fairchild CL, Gammill LS (2013) Tetraspanin18 is a FoxD3-
responsive antagonist of cranial neural crest epithelial-to-mesen-
chymal transition that maintains cadherin-6B protein. J Cell Sci 
126(Pt 6):1464–1476. https ://doi.org/10.1242/jcs.12091 5
 52. Casal JI, Bartolome RA (2019) Beyond N-cadherin, relevance of 
cadherins 5, 6 and 17 in cancer progression and metastasis. Int J 
Mol Sci. https ://doi.org/10.3390/ijms2 01333 73
 53. Dunne E, Spring CM, Reheman A, Jin W, Berndt MC, New-
man DK, Newman PJ, Ni H, Kenny D (2012) Cadherin 6 has a 
functional role in platelet aggregation and thrombus formation. 
Arterioscler Thromb Vasc Biol 32(7):1724–1731. https ://doi.
org/10.1161/ATVBA HA.112.25046 4
 54. Yue WH, Wang HF, Sun LD, Tang FL, Liu ZH, Zhang HX, Li 
WQ, Zhang YL, Zhang Y, Ma CC, Du B, Wang LF, Ren YQ, 
Yang YF, Hu XF, Wang Y, Deng W, Tan LW, Tan YL, Chen Q, 
Xu GM, Yang GG, Zuo XB, Yan H, Ruan YY, Lu TL, Han X, 
Ma XH, Wang Y, Cai LW, Jin C, Zhang HY, Yan J, Mi WF, Yin 
XY, Ma WB, Liu Q, Kang L, Sun W, Pan CY, Shuang M, Yang 
FD, Wang CY, Yang JL, Li KQ, Ma X, Li LJ, Yu X, Li QZ, 
Huang X, Lv LX, Li T, Zhao GP, Huang W, Zhang XJ, Zhang D 
564 Medical Microbiology and Immunology (2020) 209:553–564
1 3
(2011) Genome-wide association study identifies a susceptibility 
locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet 
43(12):1228–1231. https ://doi.org/10.1038/ng.979
 55. Li Z, Shen T, Xin R, Liang B, Jiang J, Ling W, Wei B, Su L (2017) 
Association of NKAPL, TSPAN18, and MPC2 gene variants with 
schizophrenia based on new data and a meta-analysis in Han Chi-
nese. Acta Neuropsychiatr 29(2):87–94. https ://doi.org/10.1017/
neu.2016.36
 56. Wu L, Chen F, Wei J, Shen Y, Xu Q (2016) Study of the tetraspa-
nin 18 association with schizophrenia in a Han Chinese popula-
tion. Psychiatry Res 241:263–266. https ://doi.org/10.1016/j.psych 
res.2016.03.057
 57. Yuan J, Jin C, Qin HD, Wang J, Sha W, Wang M, Zhang Y, Zhang 
F, Li J, Li J, Yu S, Qi S, Shugart YY (2013) Replication study 
confirms link between TSPAN18 mutation and schizophrenia in 
Han Chinese. PLoS ONE 8(3):e58785. https ://doi.org/10.1371/
journ al.pone.00587 85
 58. Zhang B, Li DX, Lu N, Fan QR, Li WH, Feng ZF (2015) Lack of 
association between the TSPAN18 gene and schizophrenia based 
on new data from Han Chinese and a meta-analysis. Int J Mol Sci 
16(6):11864–11872. https ://doi.org/10.3390/ijms1 60611 864
 59. Bauer ME, Teixeira AL (2019) Inflammation in psychiatric disor-
ders: what comes first? Ann NY Acad Sci 1437(1):57–67. https ://
doi.org/10.1111/nyas.13712 
 60. Najjar S, Pahlajani S, De Sanctis V, Stern JNH, Najjar A, Chong 
D (2017) Neurovascular unit dysfunction and blood-brain barrier 
hyperpermeability contribute to schizophrenia neurobiology: a 
theoretical integration of clinical and experimental evidence. 
Front Psychiatry 8:83. https ://doi.org/10.3389/fpsyt .2017.00083 
 61. Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, 
Whittredge PB, Fu T, Worringer K, Brown HE, Wang J, Kaykas 
A, Karmacharya R, Goold CP, Sheridan SD, Perlis RH (2019) 
Increased synapse elimination by microglia in schizophre-
nia patient-derived models of synaptic pruning. Nat Neurosci 
22(3):374–385. https ://doi.org/10.1038/s4159 3-018-0334-7
 62. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) 
The Phyre2 web portal for protein modeling, prediction and anal-
ysis. Nat Protoc 10(6):845–858. https ://doi.org/10.1038/nprot 
.2015.053
 63. Hou X, Burstein SR, Long SB (2018) Structures reveal open-
ing of the store-operated calcium channel Orai. Elife. https ://doi.
org/10.7554/eLife .36758 
 64. Hou X, Pedi L, Diver MM, Long SB (2012) Crystal structure 
of the calcium release-activated calcium channel Orai. Science 
338(6112):1308–1313. https ://doi.org/10.1126/scien ce.12287 57
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
